Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

76 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Aurora kinases: new molecular targets in thyroid cancer therapy.
Baldini E, Sorrenti S, D'Armiento E, Prinzi N, Guaitoli E, Favoriti P, Gnessi L, Moretti C, Bianchini M, Alessandrini S, Catania A, De Antoni E, Ulisse S. Baldini E, et al. Among authors: prinzi n. Clin Ter. 2012 Nov;163(6):e457-62. Clin Ter. 2012. PMID: 23306762 Review.
Selective inhibitors of aurora kinases inhibit proliferation, reduce cell viability and impair cell cycle progression in papillary thyroid carcinoma cells.
Baldini E, Tuccilli C, Prinzi N, Sorrenti S, Antonelli A, Fallahi P, Mian C, Barollo S, Catania A, Morrone S, Tartaglia F, Mascagni D, Coccaro C, Pepe M, Filippini A, D'Armiento M, Ulisse S. Baldini E, et al. Among authors: prinzi n. J Biol Regul Homeost Agents. 2015 Oct-Dec;29(4):793-803. J Biol Regul Homeost Agents. 2015. PMID: 26753639
Deregulated expression of Aurora kinases is not a prognostic biomarker in papillary thyroid cancer patients.
Baldini E, Tuccilli C, Prinzi N, Sorrenti S, Falvo L, De Vito C, Catania A, Tartaglia F, Mocini R, Coccaro C, Alessandrini S, Barollo S, Mian C, Antonelli A, De Antoni E, D'Armiento M, Ulisse S. Baldini E, et al. Among authors: prinzi n. PLoS One. 2015 Mar 25;10(3):e0121514. doi: 10.1371/journal.pone.0121514. eCollection 2015. PLoS One. 2015. PMID: 25807528 Free PMC article.
In papillary thyroid carcinoma BRAFV600E is associated with increased expression of the urokinase plasminogen activator and its cognate receptor, but not with disease-free interval.
Ulisse S, Baldini E, Sorrenti S, Barollo S, Prinzi N, Catania A, Nesca A, Gnessi L, Pelizzo MR, Mian C, De Vito C, Calvanese A, Palermo S, Persechino S, De Antoni E, D'Armiento M. Ulisse S, et al. Among authors: prinzi n. Clin Endocrinol (Oxf). 2012 Nov;77(5):780-6. doi: 10.1111/j.1365-2265.2012.04465.x. Clin Endocrinol (Oxf). 2012. PMID: 22702340
Thyroid autoantibodies and breast cancer.
Prinzi N, Baldini E, Sorrenti S, Vito CD, Tuccilli C, Catania A, Carbotta S, Mocini R, Coccaro C, Nesca A, Bianchini M, De Antoni E, D'Armiento M, Ulisse S. Prinzi N, et al. Asian Pac J Cancer Prev. 2014;15(24):10999. doi: 10.7314/apjcp.2014.15.24.10999. Asian Pac J Cancer Prev. 2014. PMID: 25605219 Free article. No abstract available.
Surgical strategies in patients with medullary thyroid carcinoma.
Sorrenti S, Guaitoli E, Catania A, D'Andrea V, Di Matteo FM, Nardi M, Prinzi N, Nardi F, Ascoli V, Baldini E, Ulisse S, De Antoni E. Sorrenti S, et al. Among authors: prinzi n. Clin Ter. 2012;163(5):e303-6. Clin Ter. 2012. PMID: 23099977
76 results